BUSINESS Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets […]
Sunrun Inc (NASDAQ: RUN) stock enjoyed a major increase of 10.5% on 3/20/24. The shares closed at $11.48. Trading volume in this advance was normal. The stock has been weak relative to the market over […]
Riot Platforms Inc (NASDAQ: RIOT) stock closed at $12.40 on 3/20/24 after a major increase of 11.8%. NORMAL trading volume accompanied the advance. The stock has risen 6.7% during the last week and has performed […]
Lifeway Foods Inc (NASDAQ: LWAY) stock enjoyed a major increase of 24.7% on 3/20/24. The shares closed at $13.58. Moreover, trading volume in this advance was exceptionally high at 435% of normal. The stock has […]
To achieve average annual stock market performance of 9.0% over the next 6 years, Lululemon Athletica shares will need to reach $648. To achieve Upper quartile performance, Lululemon Athletica’s stock price will need to reach […]
Over the next 6 years, B. Riley Financial shares will need to reach $30 to achieve average annual stock market performance of 9.0%. To achieve Upper quartile performance, B. Riley Financial’s stock price will need […]
World Acceptance Corp (NASDAQ: WRLD) suffers from extremely significant negative changes in fundamentals: the stock’s power rating fell below 50, significant quarterly sales deceleration occurred, the consensus estimate for March, 2023 decreased significantly, and the […]
Perma Fix Environmental Services (NASDAQ: PESI) stock enjoyed a major increase of 11.3% on 3/20/24. The shares closed at $10.53. Moreover, exceptionally high trading volume at 331% of normal accompanied the advance. The stock has […]
For its second fiscal quarter (ending February 28), Micron Technology Inc. (NASDAQ: MU) has reported E.P.S. of $0.72 compared to $-2.12 a year ago. For the latest four quarters through February 28, E.P.S. were $-3.44 […]
Lifecore Biomedical Inc (NASDAQ: LFCR) stock suffered a major decline of -30.3% on 3/20/24. The shares closed at $5.01. Moreover, this decline was accompanied by exceptionally high trading volume at 1697% of normal. Relative to […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research